# Implementing Cabenuva in Arkansas HIV Programs

> **NCT05096949** · NA · TERMINATED · sponsor: **University of Arkansas** · enrollment: 1 (actual)

## Conditions studied

- HIV-1-infection
- Medication Adherence
- Satisfaction, Patient

## Interventions

- **OTHER:** Home visit delivery strategy

## Key facts

- **NCT ID:** NCT05096949
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-07
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Insufficient enrollment.
- **Last updated:** 2024-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05096949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05096949, "Implementing Cabenuva in Arkansas HIV Programs". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05096949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*